Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LY86 antibody (Biotin)

This anti-LY86 antibody is a Rat Monoclonal antibody detecting LY86 in FACS. Suitable for Mouse.
Catalog No. ABIN1108080

Quick Overview for LY86 antibody (Biotin) (ABIN1108080)

Target

See all LY86 Antibodies
LY86 (Lymphocyte Antigen 86 (LY86))

Reactivity

  • 28
  • 17
  • 17
Mouse

Host

  • 39
  • 5
  • 4
Rat

Clonality

  • 41
  • 7
Monoclonal

Conjugate

  • 23
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LY86 antibody is conjugated to Biotin

Application

  • 37
  • 14
  • 13
  • 13
  • 10
  • 8
  • 7
  • 5
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Flow Cytometry (FACS)

Clone

MD113
  • Specificity

    The monoclonal antibody MD113 reacts with mouse MD-1. The antibody is antagonistic in LPS-induced B-cell proliferation and B7.2 up-regulation.

    Cross-Reactivity (Details)

    Species reactivity (tested):Mouse

    Purification

    Protein G

    Isotype

    IgG2b
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    LY86 (Lymphocyte Antigen 86 (LY86))

    Alternative Name

    LY86 / MD-1

    Background

    MD-1 (22-25 kD) is an extracellular protein associated with the extracellular domain of RP105. The latter is a type 1 transmembrane protein with leucine-rich repeats. RP105 is similar to Drosophila Toll. MD-1 associated with RP105 (similar to TLR4/MD-2) appears to be an essential molecule that helps RP105 on B-cells to signal to LPS.Synonyms: Lymphocyte antigen 86, MD1

    Gene ID

    17084

    Pathways

    Toll-Like Receptors Cascades
You are here:
Chat with us!